Health Matters: Personalized Medicine for Cancer Patients

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

UC Davis researches have partnered with Lawrence Livermore National Laboratory to use a innovative biomedical technique called Accelerator Mass Spectrometry to see how cancer patients respond or don't respond to chemo drugs. Based on their findings they're able to tailor treatment to cancer patients.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.